TrialBMC cardiovascular disorders2020

Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.

Yanqiang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.